Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.
Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 Recalled by Premier Pharmacy Labs Inc Due to Stability Date Doesn't Support Expiry: labeling error indicating...
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Premier Pharmacy Labs Inc directly.
Affected Products
Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharmacy Labs., Inc. 8265 Commercial Way Weeki Wachee, FL 34613, NDC# 69623-234-15
Quantity: 1610 syringes
Why Was This Recalled?
Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.
Where Was This Sold?
Michigan, Maryland, Minnesota, North Carolina, Ohio, Florida
About Premier Pharmacy Labs Inc
Premier Pharmacy Labs Inc has 24 total recalls tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report